Carotid sinus syndrome, should we pace? A multicentre, randomised control trial (Safepace 2)

Ryan, Daniel J.; Nick, Steen; Colette, Seifer M.; Roseanne, Kenny
March 2010
Heart;Mar2010, Vol. 96 Issue 5, p347
Academic Journal
Background Cardioinhibitory carotid sinus hypersensitivity (CICSH) is highly prevalent among older people with falls. Objective To assess the efficacy of dual-chamber pacing in older patients with CICSH and unexplained falls. Design A multicentre, double blind, randomised controlled trial. Setting Selection from emergency room, geriatric medicine and orthopaedic departments. Patients Patients aged >50 years, with two unexplained falls and/or one syncopal event in the previous 12 months for which no other cause is evident apart from CICSH. Interventions Patients randomised to either a 700/400 ?, rate responsive pacemaker or implantable loop recorder (Medtronic Reveal thera RDR, Medtronic, Minneapolis, Minnesota, USA). Main outcome measures The primary outcome was the number falls after implantation. Secondary outcomes were time to fall event, presyncope, quality of life and cognitive function. Results 141 patients were recruited from 22 centres. Mean age was 78 years and mean follow-up 24 months. The overall relative risk of falling after device implantation compared with before was 0.23 (0.15 to 0.32). No significant reduction in falls was seen between paced and loop recorder groups (RR=0.79; 95% CI 0.41 to 1.50). Data were also consistent in both groups for syncope, quality of life and cognitive function. Conclusions These results question the use of pacing in CICSH. However, the study was underpowered and also patient characteristics differed from those in Safepace 1-participants were physically and cognitively frailer. Further work is necessary to assess cardiac pacing in this setting.


Related Articles

  • Clinical trials subjects do better than regular patients.  // Applied Clinical Trials;Aug2002, Vol. 11 Issue 8, p16 

    Compares the outcomes of clinical trial subjects and regular patients who do not participate in clinical trials. Impact of participation on progress in medical research; Initiatives to increase number of subjects participating in trials.

  • Transparency rules lead to fall in positive trial results.  // BMJ: British Medical Journal;8/15/2015, Vol. 351 Issue 8021, ph4304 

    The article discusses the study on results from trials funded by U.S. National Heart, Lung, and Blood Institute (NHLBI) in "PLoS One" journal, that found fewer large clinical trials reporting positive findings since measures designed to improve transparency were introduced.

  • Measuring patients' views: the optimum outcome measure. Ware, John E. // BMJ: British Medical Journal (International Edition);5/29/93, Vol. 306 Issue 6890, p1429 

    Focuses on the need to measure medical outcomes. Standardization of self reported measures of functioning and well being; Risk of loss precision and comprehensiveness; Debate over the choice between disease specific and generic measures of outcome in clinical trials and studies of cost...

  • Interpreting Health-Related Quality-of-Life Outcomes. Kline Leidy, Nancy // Applied Clinical Trials;Sep2000, Vol. 9 Issue 9, p26 

    Focuses on the interpretation of health-related quality of life (HRQL) effects of clinical trials in the United States. Impact of clinical intervention on the patient's well-being and HRQL; Advantage of the minimal clinically important difference threshold approach; Importance of the...

  • Trial Scorecards.  // Cardiology Today;Jan2012, Vol. 15 Issue 1, p5 

    An overview of trial results in the field of cardiology is presented including one on the outcomes of a pharmacist-led intervention in patients with heart failure, one on a comparison of treatments in patients with aortoiliac peripheral artery disease and another on second-generation zotarolimus...

  • Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study. Ashizawa, Tetsuo; Figueroa, Karla P.; Perlman, Susan L.; Gomez, Christopher M.; Wilmot, George R.; Schmahmann, Jeremy D.; Ying, Sarah H.; Zesiewicz, Theresa A.; Paulson, Henry L.; Shakkottai, Vikram G.; Bushara, Khalaf O.; Kuo, Sheng-Han; Geschwind, Michael D.; Xia, Guangbin; Mazzoni, Pietro; Krischer, Jeffrey P.; Cuthbertson, David; Holbert, Amy Roberts; Ferguson, John H.; Pulst, Stefan M. // Orphanet Journal of Rare Diseases;2013, Vol. 8 Issue 1, p1 

    Background All spinocerebellar ataxias (SCAs) are rare diseases. SCA1, 2, 3 and 6 are the four most common SCAs, all caused by expanded polyglutamine-coding CAG repeats. Their pathomechanisms are becoming increasingly clear and well-designed clinical trials will be needed. Methods To...

  • Assessing Treatment Outcomes in Toenail Onychomycosis Clinical Trials. Werschler, W. Philip; Bondar, George; Armstrong, David // American Journal of Clinical Dermatology;2004, Vol. 5 Issue 3, p145 

    Several oral and topical medications are available for the treatment of onychomycosis, a widespread fungal infection of the nail. Since efficacy criteria vary greatly among clinical trials for onychomycosis treatment, it is difficult for physicians to compare outcomes and determine the...

  • Patient-Reported Outcomes in Gastroenterology: Clinical and Research Applications. Spiegel, Brennan M. R. // Journal of Neurogastroenterology & Motility;Apr2013, Vol. 19 Issue 2, p137 

    Patient-generated reports, also known as Patient-Reported Outcomes (PROs), capture the patients' illness experience in a structured format and may help bridge the gap between patients and providers. PROs measure any aspect of patient-reported health (e.g., physical, emotional or social symptoms)...

  • 2C or not 2C: defining an improved revascularization grading scale and the need for standardization of angiography outcomes in stroke trials. Goyal, Mayank; Fargen, Kyle M; Turk, Aquilla S; Mocco, J; Liebeskind, David S; Demchuk, Andrew M; Frei, Donald // Journal of NeuroInterventional Surgery;Mar2014, Vol. 6 Issue 2, p83 

    The authors discuss the aspects of improved grading scale for revascularization and the standardization of angiography results in stroke trials. Topics discussed include existing revascularization scales, variability in reporting trials, and recanalization and reperfusion, which is the two...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics